<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) October 12, 2000
SONUS PHARMACEUTICALS, INC.
(Exact name of Registrant as specified in its charter)
Delaware 0-26866 95-4343413
---------------------------- ------------ ------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No)
22026 20th Avenue S.E., Bothell, Washington 98021
---------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (425) 487-9500
Not Applicable
(Former name or former address, if changed since last report)
Page 1 of 6
Exhibit Index on Page 4
<PAGE> 2
ITEMS 1 THROUGH 4, 6, 8 AND 9 ARE NOT APPLICABLE.
ITEM 5. OTHER EVENTS
Reference is made to the press release issued to the public by the
registrant on October 12, 2000, the text of which is attached hereto as Exhibit
99.1, for a description of the events reported pursuant to this Form 8-K.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements
Not Applicable
(b) Pro Forma Financial Information
Not Applicable
(c) Exhibits
<TABLE>
<CAPTION>
EXHIBIT NO. DESCRIPTION
----------- -----------
<S> <C>
99.1 Press Release dated October 12, 2000.
</TABLE>
2
<PAGE> 3
SIGNATURE
In accordance with the requirements of the Securities Exchange Act, the
registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
SONUS PHARMACEUTICALS, INC.
Date: October 19, 2000 By: /s/ Richard J. Klein
---------------------------------
Richard J. Klein
Vice President of Finance and
Chief Financial Officer
(Duly Authorized Officer and Principal
Financial and Accounting Officer)
3
<PAGE> 4
EXHIBIT INDEX
<TABLE>
<CAPTION>
EXHIBIT NO. DESCRIPTION
----------- -----------
<S> <C>
99.1 Press Release dated October 12, 2000.
</TABLE>
4
